For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
6
views
0
references
 Top references
cited by
0
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      5,189
      similar
       All similar
      • Record: found
      • Abstract: not found
      • Article: not found

      Millennium Pharmaceuticals Ortho Biotech, a division of Janssen-Cilag emerging therapies for relapsed and refractory lymphoid neoplasms

      Publication date Created:
      Publication date (Print):
      Journal: Annals of Oncology
      Publisher: Oxford University Press (OUP)

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          Title: Annals of Oncology
          Abbreviated Title: Annals of Oncology
          Publisher: Oxford University Press (OUP)
          ISSN (Print): 09237534
          Publication date Created: June 2008
          Publication date (Print): June 2008
          Volume: 19
          Page: iv275
          Article
          DOI: 10.1093/annonc/mdn268
          SO-VID: 4d26b145-4140-4ef8-939b-e805df0fb509
          Copyright © © 2008
          License:

          https://www.elsevier.com/tdm/userlicense/1.0/

          http://www.elsevier.com/open-access/userlicense/1.0/

          History

          Data availability:

          Comments

          Comment on this article